Steven D. Rubin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Miami, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Steven D. Rubin
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steven D. Rubin

Form 4 holding Executive VP-Administration, Director

OPKO HEALTH, INC.

Security class
Common Stock
Shares / value
6,625,232
Estimated value
$8,380,918
Report date
24 Jul 2024
Price
$1.26
Ownership
Direct
Form 4 holding Executive VP-Administration, Director

OPKO HEALTH, INC.

Security class
Stock Option (Right to Buy)
Shares / value
437,500
Estimated value
Report date
27 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cocrystal Pharma, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
16,410
Estimated value
Report date
09 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Steven D. Rubin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .